The study of neutrophils to lymphocyte ratio in moderately controlled diabetes (HbA1c 7-9) and its correlation with microvascular complications
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260614Keywords:
Type2 DM, NLR-neutrophil-lymphocyte ratio, Microvascular complicationsAbstract
Background: The study of neutrophils to lymphocyte ratio in moderately controlled diabetes (HbA1c 7-9) and its correlation with microvascular complications are to measure neutrophil lymphocyte ratio in patients with moderately controlled type 2 diabetes mellitus and to determine the correlation between neutrophil lymphocyte ratio and microvascular complications in moderately controlled type 2 diabetes patients.
Methods: Prospective, cross-sectional study, carried out on the patients with type 2 diabetes mellitus patients with hba1c levels 7 to 9, who are attending medicine opd and admitted under medicine. Complete blood count, fundoscopy, urine microalbumin and monofilament were analysed in these patients.
Results: This study shows that more than half (63%) of the study participants were males and 37% were females. Most of the patients came for follow up (81%). In our study it was observed that patient with microvascular complications like retinopathy, nephropathy and neuropathy had higher NLR when compared with patients with no microvascular complications.
Conclusions: Our study revealed that NLR was significantly raised in T2DM patients with microvascular complications. NLR being a simple, cost effective and easily available investigation can be used for screening tool to detect diabetic micro complications at an earliest especially in a resource constrained setup with limited laboratory facilities. Hence, NLR can be considered as a potential alternative for other costlier inflammatory markers and also a prognostic biomarker of any microvascular complications among T2DM patients.
Metrics
References
Phadnis N, Shiddapur GS, Harsh P, Rana N. A Comparative Study Evaluating The role of Utility of Red Blood Cell Count, Red Cell Distribution Width, And Neutrophil/Lymphocyte Ratio as Prognostic Markers in Type 2 Diabetes Mellitus patients with and without Microvascular Complications. Euro J Molecul Clin Med. 2022;9:8414-24.
Gurmu MZ, Genet S, Gizaw ST, Feyisa TO, Gnanasekaran N. Neutrophil–lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: A comparative cross-sectional study. SAGE Open Med. 2022;10:1–7. DOI: https://doi.org/10.1177/20503121221140231
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Endocrinology. 2018;14:88-98. DOI: https://doi.org/10.1038/nrendo.2017.151
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69:2932-8. DOI: https://doi.org/10.4103/ijo.IJO_1627_21
Govindaswamy S, Dhivya PS, Sangeetha SKS. Prevalence and Complications of Diabetes Mellitus in India-A Systematic Review. Ind J Pharmaceut Educ Res. 2023;57(2):213-25. DOI: https://doi.org/10.5530/ijper.57.2s.25
Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, HS. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afri Health Sci. 2019;19(1):1602-6. DOI: https://doi.org/10.4314/ahs.v19i1.35
Fawwad A, Butt AM, Siddiqui IA, Khalid M, Sabir R, Basit A. Neutrophil-to-lymphocyte ratio and microvascular complications insubjects with type 2 diabetes: Pakistan′s perspective. Turk J Med Sci. 2018;48:157-61. DOI: https://doi.org/10.3906/sag-1706-141
Kothai G, Neha K, Bholenath Patil A. Neutrophil lymphocyte ratio as a marker of diabetic nephropathy. J. Evid. Based Med. Healthc. 2020;7(26):1223-7. DOI: https://doi.org/10.18410/jebmh/2020/261
Wan H, Wang Y, Fang S, Chen Y, Zhang W, Xia F, et al. Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. J Diabetes Res. 2020;2(1):1-9. DOI: https://doi.org/10.1155/2020/6219545
DiGangi C. Neutrophil-lymphocyte ratio: Predicting cardiovascular and renal complications in patients with diabetes. J Am Assoc Nurse Practition. Brief report; 2016. DOI: https://doi.org/10.1002/2327-6924.12366
Khandare SA, Chittawar S, Nahar N, Dubey TN, Qureshi Z. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian J Endocr Metab. 2017;21:387-92. DOI: https://doi.org/10.4103/ijem.IJEM_476_16
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, et al. The relationship between neutrophil-tolymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus. Medicine. 2017;96:45. DOI: https://doi.org/10.1097/MD.0000000000008289
Moursy EY, Megallaa MH, Mouftah RF, Ahmed SM. Relationship Between Neutrophil-Lymphocyte Ratio and Microvascular Complications in Egyptian Patients with Type 2 Diabetes. Am J Internal Med. 2015;3:250-5. DOI: https://doi.org/10.11648/j.ajim.20150306.16
Kahraman C, Kahraman NK, Aras B, Coşgun S, Gülcan E. The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study. Arch Med Sci. 2016;12(3):571–5. DOI: https://doi.org/10.5114/aoms.2016.59931
Ozturk ZA, Kuyumcu ME, Yesil Y, Savas E, Yıldız H, Kepekci Y, et al. Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients. J Endocrinol Invest. 2013;36:593-9.
Chittawar S, Dutta D, Qureshi Z, Surana V, Khandare S, Dubey TN. Neutrophil-lymphocyte ratio is a novel reliable predictor of nephropathy, retinopathy, and coronary artery disease in Indians with type-2 diabetes. Indian J Endocr Metab. 2017;21:864-70. DOI: https://doi.org/10.4103/ijem.IJEM_197_17
Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015;8(7):11420-7.
Downloads
Published
How to Cite
Issue
Section
